Legislating for transparency not the answer
These important interactions should be subject to scrutiny, and be able to withstand that scrutiny.
However, the Greens’ proposal to introduce legislation to ban or limit these relationships is unnecessary on several levels.
First, the proposal to prevent pharmaceutical companies from covering the travel expenses of practitioners attending educational meetings and conferences could dissuade doctors from attending. It is unclear who would cover these costs if companies were legally prevented from doing so. If doctors had to fund their own travel, a consequence may well be that doctors would attend fewer meetings. The end result would likely be doctors having less interaction with their peers and being less likely to stay up to date with information on new treatments and adverse events. Patients would be the losers.
Second, several of the restrictions the Greens propose have been in place for many years. The Medicines Australia Code of